top of page

Latest News

Aug 1, 2023

We are starting the research project: "Metabolomics profiles of chronic low back pain and fibromyalgia"

Collaborator: Merck & Co., Inc

Read More
We are starting the research project: "Metabolomics profiles of chronic low back pain and fibromyalgia"

Sep 28, 2022

The NIH funds our large project on the mechanisms of human pain

A collaboration with Ted Price (University of Texas at Dallas), Pat Dougherty (MD Anderson Cancer Center), and Christoph Hofstetter (University of Washington)

Read More
The NIH funds our large project on the mechanisms of human pain

Sep 1, 2021

The NIH approves funding for our 5-year project on neck pain

We use RNA sequencing from neck tissues and advanced phenotyping to identify new treatment targets for chronic pain.

Read More
The NIH approves funding for our 5-year project on neck pain

May 1, 2021

The Lancet Rheumatology publishes our review

Central sensitization in chronic pain conditions

Read More
The Lancet Rheumatology publishes our review

May 1, 2021

Excellent point of view in JAMA: The term “provider” should not be used

Beasley JW, Roberts RG, Goroll AH. Promoting Trust and Morale by Changing How the Word Provider Is Used: Encouraging Specificity and Transparency. JAMA. 2021;325(23):2343–2344. doi:10.1001/jama.2021.6046

Read More
Excellent point of view in JAMA: The term “provider” should not be used

May 1, 2021

Publication of our paper in Neuron

A proposal for multi-institutional efforts to understand the human neurobiology of pain and identify therapeutic targets

Read More
Publication of our paper in Neuron

Apr 1, 2021

Modulation of the oxytocin receptor could be promising for pain management

Our study using experimental pain models

Read More
Modulation of the oxytocin receptor could be promising for pain management
bottom of page